|
Volumn 2, Issue 1, 2002, Pages 31-42
|
Phase I radioimmunotherapy trial with iodine-131-labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer
a a a a a b b a a a |
Author keywords
Carcinoembryonic antigen; Dosimetry; Humanized antibody; Radioimmunotherapy; Tumor targeting
|
Indexed keywords
CARCINOEMBRYONIC ANTIGEN;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY MN 14;
MONOCLONAL ANTIBODY MN-14;
IMMUNOGLOBULIN G;
IODINE 131;
UNCLASSIFIED DRUG;
ADENOCARCINOMA;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COLORECTAL TUMOR;
CONFIDENCE INTERVAL;
FEMALE;
GASTROINTESTINAL TUMOR;
HUMAN;
IMMUNOLOGY;
MALE;
METASTASIS;
MIDDLE AGED;
PANCREAS TUMOR;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
RADIOIMMUNOTHERAPY;
ADVANCED CANCER;
ALGORITHM;
BLOOD TOXICITY;
BONE MARROW;
CLINICAL ARTICLE;
COLORECTAL CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC IMAGING;
DIAGNOSTIC TEST;
DIGESTIVE SYSTEM CANCER;
DOSE RESPONSE;
DOSIMETRY;
DRUG DISTRIBUTION;
DRUG HALF LIFE;
DRUG INFUSION;
DRUG TARGETING;
DRUG TOLERABILITY;
ISOTOPE LABELING;
PHARMACOKINETICS;
RADIATION ABSORPTION;
RADIATION DOSE;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
CARCINOEMBRYONIC ANTIGEN;
COLORECTAL NEOPLASMS;
CONFIDENCE INTERVALS;
FEMALE;
GASTROINTESTINAL NEOPLASMS;
HUMANS;
MALE;
MIDDLE AGED;
PANCREATIC NEOPLASMS;
RADIOIMMUNOTHERAPY;
|
EID: 0036018888
PISSN: 15330028
EISSN: None
Source Type: Journal
DOI: 10.3816/CCC.2002.n.009 Document Type: Article |
Times cited : (50)
|
References (58)
|